ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on: June 28,2024 8

Research could lead to more precise diagnosis and treatment of ovarian cancer

by Michael Brown,University of Alberta Faculty of Medicine & DentistryLynne Postovit co-led a new study identifying eight biomarkers that enable pathologists to differentiate between two typ

Updated on:June 28,2024 8

Potential overtreatment during life-limiting illness and end of life in older adults

by Gunilla Sonnebring,Karolinska InstitutetCredit: CC0 Public DomainA new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoi

Updated on: April 22,2024 13

Potential overtreatment during life-limiting illness and end of life in older adults

by Gunilla Sonnebring,Karolinska InstitutetCredit: CC0 Public DomainA new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoi

Updated on:April 22,2024 13

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva

Updated on: January 16,2024 17

Study shows physical activity prevents cancer recurrence in patients previously treated for colon cancer

by Pennington Biomedical Research CenterPlots of the confounder-adjusted continuous-time estimate of the log-hazard ratios for (A) disease-free survival, (B) time to recurrence and (C) overall surviva

Updated on:January 16,2024 17

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024 18

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024 18

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024 0

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024 0

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on: September 30,2024 0

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on:September 30,2024 0

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on: January 23,2024 10

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on:January 23,2024 10

Promising new treatment for rare pregnancy cancer leads to remission in patients

by Maxine Myers,Imperial College LondonCredit: Imperial College LondonAn immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments hav

Updated on: May 07,2024 19

Promising new treatment for rare pregnancy cancer leads to remission in patients

by Maxine Myers,Imperial College LondonCredit: Imperial College LondonAn immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments hav

Updated on:May 07,2024 19

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on: January 29,2024 13

A new targeted treatment shows promise for select patients with stomach cancer

byWeill Cornell Medical CollegeCredit: Pixabay/CC0 Public DomainAn international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found tha

Updated on:January 29,2024 13

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on: February 18,2024 17

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on:February 18,2024 17

Stopping a rare childhood cancer in its tracks

byCold Spring Harbor LaboratoryScientists discovered targeting a protein called ETV6 can turn Ewing sarcoma cancer cells back to normal-looking and -behaving connective tissue cells, as seen abo

Updated on: January 22,2024 18

Stopping a rare childhood cancer in its tracks

byCold Spring Harbor LaboratoryScientists discovered targeting a protein called ETV6 can turn Ewing sarcoma cancer cells back to normal-looking and -behaving connective tissue cells, as seen abo

Updated on:January 22,2024 18